FDA inspection
Rendell, Dr Marc S: FDA inspection ending Jul 8, 2008
FDA inspection 526679 · No Action Indicated (NAI) · Omaha, NE
Key facts
| Inspection ID | 526679 |
|---|---|
| Firm | Rendell, Dr Marc S |
| FEI number | 3000214926 |
| Address | 601 N 30th St Ste 6715, Creighton Diabetes Center |
| City | Omaha |
| State | NE |
| ZIP | 68131-2137 |
| Fiscal year | 2008 |
| Inspection end date | Jul 8, 2008 |
| Classification | No Action Indicated (NAI) |
| Project area | Bio-Research Monit: Human Drugs |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data